Aze Wilson

969 total citations
39 papers, 669 citations indexed

About

Aze Wilson is a scholar working on Genetics, Epidemiology and Oncology. According to data from OpenAlex, Aze Wilson has authored 39 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 14 papers in Epidemiology and 12 papers in Oncology. Recurrent topics in Aze Wilson's work include Inflammatory Bowel Disease (22 papers), Microscopic Colitis (9 papers) and Drug Transport and Resistance Mechanisms (5 papers). Aze Wilson is often cited by papers focused on Inflammatory Bowel Disease (22 papers), Microscopic Colitis (9 papers) and Drug Transport and Resistance Mechanisms (5 papers). Aze Wilson collaborates with scholars based in Canada, United Kingdom and United States. Aze Wilson's co-authors include Richard B. Kim, Wendy A. Teft, Rommel G. Tirona, Bridget L. Morse, Robert A. Hegele, Terry Ponich, Qian Wang, Yun‐Hee Choi, Nilesh Chande and Michael Sey and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and PLoS ONE.

In The Last Decade

Aze Wilson

36 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aze Wilson Canada 14 246 179 165 163 106 39 669
Danuta Owczarek Poland 16 326 1.3× 185 1.0× 162 1.0× 187 1.1× 55 0.5× 50 876
Mayur Garg Australia 14 246 1.0× 153 0.9× 147 0.9× 246 1.5× 96 0.9× 46 866
Mehmet Yücesoy Türkiye 17 95 0.4× 111 0.6× 164 1.0× 301 1.8× 151 1.4× 40 817
Xixian Ruan China 12 173 0.7× 139 0.8× 122 0.7× 104 0.6× 40 0.4× 27 524
Ashok Kumar Kumawat Sweden 12 174 0.7× 190 1.1× 82 0.5× 285 1.7× 92 0.9× 33 716
Dale R. Bachwich United States 8 202 0.8× 110 0.6× 239 1.4× 129 0.8× 103 1.0× 15 686
Aleksandra Szymczak‐Tomczak Poland 16 290 1.2× 128 0.7× 140 0.8× 215 1.3× 40 0.4× 48 634
Lars Erik Bartels Denmark 14 264 1.1× 95 0.5× 83 0.5× 330 2.0× 49 0.5× 22 820
Michał Drews Poland 15 170 0.7× 205 1.1× 385 2.3× 84 0.5× 170 1.6× 63 856
Athanasios Vergopoulos Germany 15 85 0.3× 129 0.7× 273 1.7× 150 0.9× 110 1.0× 28 915

Countries citing papers authored by Aze Wilson

Since Specialization
Citations

This map shows the geographic impact of Aze Wilson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aze Wilson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aze Wilson more than expected).

Fields of papers citing papers by Aze Wilson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aze Wilson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aze Wilson. The network helps show where Aze Wilson may publish in the future.

Co-authorship network of co-authors of Aze Wilson

This figure shows the co-authorship network connecting the top 25 collaborators of Aze Wilson. A scholar is included among the top collaborators of Aze Wilson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aze Wilson. Aze Wilson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cipriano, Lauren E., Cassandra McDonald, Mayur Brahmania, et al.. (2024). Propofol sedation does not improve measures of colonoscopy quality but increase cost – findings from a large population-based cohort study. EClinicalMedicine. 70. 102503–102503. 2 indexed citations
3.
Wilson, Aze, et al.. (2024). P783 Exploring the impact of JAK Inhibitors on cholesterol levels in Patients with Inflammatory Bowel Disease: A Real-World Data Analysis. Journal of Crohn s and Colitis. 18(Supplement_1). i1451–i1451. 1 indexed citations
4.
Choi, John, Qian Wang, Melanie Beaton, et al.. (2024). Infliximab Tissue Concentrations in Patients With Stable Ulcerative Colitis Are Correlated With More Durable Infliximab-associated Disease Remission. Inflammatory Bowel Diseases. 30(11). 2174–2180. 1 indexed citations
5.
Solitano, Virginia, Antonio Facciorusso, Dermot McGovern, et al.. (2023). HLA-DQA1∗05 Genotype and Immunogenicity to Tumor Necrosis Factor-α Antagonists: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology. 21(12). 3019–3029.e5. 28 indexed citations
6.
McDonald, Cassandra, Leonardo Guizzetti, Alla Iansavichene, et al.. (2023). Endoscopy Unit Level Interventions to Improve Adenoma Detection Rate: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology. 21(13). 3238–3257. 3 indexed citations
7.
8.
Khanna, Reena, et al.. (2022). Increased Hospitalization for IBD Patients Seen in the ER During the COVID-19 Pandemic. Journal of the Canadian Association of Gastroenterology. 5(6). 271–275. 3 indexed citations
9.
Guo, Angela, Nilesh Chande, Jamie Gregor, et al.. (2022). High oncostatin M predicts lack of clinical remission for patients with inflammatory bowel disease on tumor necrosis factor α antagonists. Scientific Reports. 12(1). 1185–1185. 26 indexed citations
10.
11.
Imasogie, Ngozi, et al.. (2021). High quantities: Evaluating the association between cannabis use and propofol anesthesia during endoscopy. PLoS ONE. 16(3). e0248062–e0248062. 20 indexed citations
12.
13.
Heath, Emily, Richard B. Kim, & Aze Wilson. (2021). A Comparative Analysis of Drug Therapy, Disease Phenotype, and Health Care Outcomes for Men and Women with Inflammatory Bowel Disease. Digestive Diseases and Sciences. 67(9). 4287–4294. 10 indexed citations
14.
Wilson, Aze, et al.. (2020). Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn’s disease. Scientific Reports. 10(1). 1866–1866. 53 indexed citations
15.
Wilson, Aze, et al.. (2019). HLADQA1*05 genotype predicts anti‐drug antibody formation and loss of response during infliximab therapy for inflammatory bowel disease. Alimentary Pharmacology & Therapeutics. 51(3). 356–363. 63 indexed citations
16.
Wilson, Aze, Rommel G. Tirona, & Richard B. Kim. (2017). CYP3A4 Activity is Markedly Lower in Patients with Crohnʼs Disease. Inflammatory Bowel Diseases. 23(5). 804–813. 22 indexed citations
17.
Wilson, Aze, et al.. (2016). Trimethylamine-N-oxide. Current Opinion in Lipidology. 27(2). 148–154. 62 indexed citations
18.
Wilson, Aze, et al.. (2015). Using GIS to assess the impact of childhood environments on obesity. University of Canterbury Research Repository (University of Canterbury). 1 indexed citations
19.
Wilson, Aze, Wendy A. Teft, Bridget L. Morse, et al.. (2015). Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease. Digestive Diseases and Sciences. 60(12). 3620–3630. 77 indexed citations
20.
Wilson, Aze, Wendy A. Teft, Rommel G. Tirona, et al.. (2015). Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease. The American Journal of Gastroenterology. 110. S773–S773. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Danuta Owczarek Breakdown of academic impact, for papers by Mayur Garg Breakdown of academic impact, for papers by Mehmet Yücesoy Breakdown of academic impact, for papers by Xixian Ruan Breakdown of academic impact, for papers by Ashok Kumar Kumawat Breakdown of academic impact, for papers by Dale R. Bachwich Breakdown of academic impact, for papers by Aleksandra Szymczak‐Tomczak Breakdown of academic impact, for papers by Lars Erik Bartels Breakdown of academic impact, for papers by Michał Drews Breakdown of academic impact, for papers by Athanasios Vergopoulos
Rankless by CCL
2026